Table 1 The association of DACT2 methylation status and clinical factors in human breast cancer patients.
From: Methylation of DACT2 promotes breast cancer development by activating Wnt signaling
Methylation status | ||||
---|---|---|---|---|
Clinical parameter | Number (n = 153) | Unmethylated N = 77(50.3%) | Methylated N = 76(49.7%) | p value |
Age | ||||
<50 | 72 | 38 | 34 | 0.57 |
≥50 | 81 | 39 | 42 | |
Tumor grade | ||||
I–II | 93 | 44 | 49 | 0.35 |
III | 60 | 33 | 27 | |
Tumor stage | ||||
1–2 | 121 | 63 | 58 | 0.40 |
3–4 | 32 | 14 | 18 | |
Tumor size | ||||
<4 cm | 114 | 63 | 51 | 0.037* |
≥4 cm | 39 | 14 | 25 | |
Lymph node metastasis | ||||
no | 79 | 44 | 35 | 0.17 |
yes | 74 | 33 | 41 | |
ER status | ||||
Positive | 30 | 15 | 15 | 0.97 |
Negative | 123 | 62 | 61 | |
PR status | ||||
Positive | 48 | 23 | 25 | 0.69 |
Negative | 105 | 54 | 51 | |
HER2 status | ||||
Positive | 131 | 68 | 63 | 0.57 |
Negative | 22 | 9 | 13 |